I am shocked.
Shocked, I tell you, to hear that a study by the Center for Science in the Public Interest discovered that
10 of the 32 panel members who voted that a group of powerful pain killers should continue to be sold had ties to the two corporations that manufacture the drugs they were voting on, either Pfizer Inc., or Merck
& Co. Their involvement ranged from consulting fees and speaking honoraria to
receiving research support from the companies.

More details here.

Why can’t we separate government regulation from government advocacy?

Why don’t we split each federal regulatory agency into two equal but independent organizations – one to strictly regulate and another agency to strongly advocate?

The special interests would lobby whichever side they were on, and the competition and tension between the two agencies would tend to even out the these swings between over regulation and our current catch-me-if-can system.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: